# Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation

> **NCT00501241** · PHASE2 · TERMINATED · sponsor: **Procter and Gamble** · enrollment: 214 (estimated)

## Conditions studied

- Chronic Constipation

## Interventions

- **DRUG:** ATI-7505
- **DRUG:** ATI-7505
- **DRUG:** ATI-7505
- **DRUG:** ATI-7505
- **DRUG:** ATI-7505

## Key facts

- **NCT ID:** NCT00501241
- **Lead sponsor:** Procter and Gamble
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 214 (ESTIMATED)
- **Last updated:** 2009-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00501241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00501241, "Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00501241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*